Abstract: A compound represented by general formula [I] wherein X represents N or the like, Y represents CH or the like; RA represents a cycloalkyl group which may be substituted or the like, R1 represents an alkyl group or the like, R2 represents an alkyl group which may be substituted or the like, R3 represents a hydrogen atom or an alkyl group, or a pharmaceutically acceptable salt thereof has an inhibitory activity on aldosterone synthetase, and is useful as a prophylactic and/or therapeutic agent for various diseases or symptoms associated with aldosterone.

Abstract: An operation lever for a working vehicle, the operation lever being arranged to one side of an operator seat of the working vehicle, includes: a swing body configured to be swingable; and a grip arranged on an upper portion of the swing body. The grip includes: a gripping arranged to the one side; an operating portion arranged to another side opposed to the one side and provided with an operation switch; an extending portion extending backward from a lower portion of the gripping portion; and an anti-slip portion arranged between a surface of the gripping portion and a surface of the extending portion.

Abstract: A multi-purpose vehicle includes a seat provided between front wheels and rear wheels, a load carrying deck provided on a rear side of the seat, a right tail lamp provided on a right lower side of a rear portion of the load carrying deck, a left tail lamp provided on a left lower side of the rear portion of the load carrying deck, a right tail lamp guard provided on rear side of the right tail lamp and connected to the load carrying deck, a left tail lamp guard provided on rear side of the left tail lamp and connected to the load carrying deck, and a rear bumper. The rear bumper is connected to and between the right tail lamp guard and the left tail lamp guard.

Abstract: Provided is a model parameter learning device and the like capable of learning model parameters such that the influence of a noise in input data can be suppressed. A model parameter learning device (1) alternately carries out first learning processing for learning model parameters W1, b1, W2 and b2 such that an error between data Xout and data Xorg is minimized, and second learning processing for learning model parameters W1, b1, Wm, bm, Wq and bq such that a loss function LAE is minimized.

Abstract: This invention provides a novel disubstituted 1,2,4-triazine compound or a pharmaceutically acceptable salt thereof, which has an aldosterone synthetase inhibitory activity and is useful for preventing and/or treating various diseases or conditions associated with aldosterone; a method for preparing it; use of it; as well as a pharmaceutical composition comprising it as an active ingredient. A compound of the general formula [I]: wherein RA is, for example, a group of the following formula (A-1): wherein ring A1 is, for example, a cycloalkyl group which may be substituted, and RB is, for example, a monocyclic cycloalkyl group, or a pharmaceutically acceptable salt thereof.

Abstract: Control facilities and incidental facilities in fields are flexibly managed. Since identification information enabling to identify uniquely information regarding control facilities of which design timing and architectures are mutually different or facilities incidental to the control facilities is encoded, pieces of identification information are coupled and uniqueness is guaranteed. Further, a parent-child relation between identifiers is constructed and the identifiers are structured as a tree structure based on the structure of the control facilities. A control facility operation management device manages combination of the structured identifiers and information of management target or combination of the structured identification information and identification information of a database.

Abstract: A multi-purpose vehicle includes a seat provided between front wheels and rear wheels, a load carrying deck provided on a rear side of the seat, a right tail lamp provided on a right lower side of a rear portion of the load carrying deck, a left tail lamp provided on a left lower side of the rear portion of the load carrying deck, a right tail lamp guard provided on rear side of the right tail lamp and connected to the load carrying deck, a left tail lamp guard provided on rear side of the left tail lamp and connected to the load carrying deck, and a rear bumper. The rear bumper is connected to and between the right tail lamp guard and the left tail lamp guard.

Abstract: A compound represented by general formula [I] wherein X represents N or the like, Y represents CH or the like; RA represents a cycloalkyl group which may be substituted or the like, R1 represents an alkyl group or the like, R2 represents an alkyl group which may be substituted or the like, R3 represents a hydrogen atom or an alkyl group, or a pharmaceutically acceptable salt thereof has an inhibitory activity on aldosterone synthetase, and is useful as a prophylactic and/or therapeutic agent for various diseases or symptoms associated with aldosterone.

Abstract: This invention provides a novel disubstituted 1,2,4-triazine compound or a pharmaceutically acceptable salt thereof, which has an aldosterone synthetase inhibitory activity and is useful for preventing and/or treating various diseases or conditions associated with aldosterone; a method for preparing it; use of it; as well as a pharmaceutical composition comprising it as an active ingredient. A compound of the general formula [I]: wherein RA is, for example, a group of the following formula (A-1): wherein ring A1 is, for example, a cycloalkyl group which may be substituted, and RB is, for example, a monocyclic cycloalkyl group, or a pharmaceutically acceptable salt thereof.

Abstract: This invention provides a novel disubstituted 1,2,4-triazine compound or a pharmaceutically acceptable salt thereof, which has an aldosterone synthetase inhibitory activity and is useful for preventing and/or treating various diseases or conditions associated with aldosterone; a method for preparing it; use of it; as well as a pharmaceutical composition comprising it as an active ingredient. A compound of the general formula [I]: wherein RA is, for example, a group of the following formula (A-1): wherein ring A1 is, for example, a cycloalkyl group which may be substituted, and RB is, for example, a monocyclic cycloalkyl group, or a pharmaceutically acceptable salt thereof.

Abstract: An oxide film removing method is a method of removing an oxide film formed in a surface of a superalloy part that contains a first metal as a base metal and a second metal different from the first metal. The oxide film removing method includes arranging the superalloy part inside a heating chamber; reducing the oxide of the base metal to the base metal by heating the inside of the heating chamber in a condition that a reduction gas atmosphere or a vacuum atmosphere is maintained; and carrying out acid processing to apply acid solution to the superalloy part after the reduction. The oxide film formed in the surface of the superalloy is removed effectively without using a highly toxic gaseous fluoride.

Abstract: A radiography system includes an imaging controller, a reconstruction processor, a process sequence controller and a display section. The imaging controller controls a radiation source to move in a range of a designated sweep angle and project X-rays at different angles to an imaging subject, while controlling a flat panel detector to acquire a set of projection images. The reconstruction processor uses the set of projection images to produce a plurality of tomographic images for use in diagnosis. The process sequence controller determines a parameter for sorting the plurality of tomographic images into first and second groups according to the sweep angle of the radiation source so as the first group of tomographic images to be produced prior to the second group of tomographic images. The display section displays at least the first group of tomographic images.